Latest | Instant Finance & Market News_第472页 | NewTimeSpace

09:36

[ SUNDART HLDGS (01568.HK) plans to issue up to 22 million shares by placement, with estimated net proceeds of HKD 14.2 million ] NewTimeSpace News: SUNDART HLDGS (01568.HK) plans to issue up to 22 million shares by placement, with estimated net proceeds of HKD 14.2 million.

Tag： SUNDART HLDGS 01568.HK placement

09:35

[ REACH NEW HLDGS (08471.HK) plans to issue up to 245.2 million shares by placement, with estimated net proceeds of HKD 4.7 million ] NewTimeSpace News: REACH NEW HLDGS (08471.HK) plans to issue up to 245.2 million shares by placement, with estimated net proceeds of HKD 4.7 million.

Tag： REACH NEW HLDGS 08471.HK placement

09:08

[ SINOHYTEC(02402.HK)2025 Annual Report - Profit Attributable to Shareholders stood at loss of CNY 618.5 million, loss widened by 36.9% YoY ] NewTimeSpace News,May 04, 2026, SINOHYTEC(02402.HK) released its Annual Report for the period ended December 31, 2025, Total Revenue stood at CNY 258.54 million, decreased by 29.49% YoY

Tag： SINOHYTEC 02402.HK NewTimeSpace

09:07

[ BUD APAC(01876.HK)2026 Q1 Report - Profit Attributable to Shareholders stood at USD 226 million, YoY decrease of 3.42% ] NewTimeSpace News,May 05, 2026, BUD APAC(01876.HK) released its Q1 Report for the period ended December 31, 2026, Total Revenue stood at USD 1.49 billion, increased by 2.19% YoY

Tag： BUD APAC 01876.HK NewTimeSpace

08:00

[ Raybow Biotech - B (6938.HK): Achieves Third Key Milestone in MASH R&D Collaboration with Boehringer Ingelheim ] NewTimeSpace News: Suzhou Raybow Biotech Co., Ltd. (06938.HK) announced that it has achieved the third key milestone in its R&D collaboration with Boehringer Ingelheim (BI) for developing innovative therapeutic solutions for liver diseases (including Metabolic Dysfunction-Associated Steatohepatitis, MASH). MASH is a severe and progressive fatty liver disease affecting over 200 million people worldwide.

Tag： Raybow Biotech-B 06938.HK BI R&D collaboration

07:37

[ SIMCERE PHARMA (02096.HK): SIM0613 (LRRC15 ADC) Receives NMPA Clinical Trial Approval ] NewTimeSpace News: Simcere Pharmaceutical Group Limited (02096.HK) announced that SIM0613 for Injection, a self-developed antibody-drug conjugate (ADC) targeting LRRC15, has obtained the Clinical Trial Approval Notice issued by the National Medical Products Administration (NMPA). A clinical trial for advanced solid tumors is planned to be launched. Previously, Simcere Zaiming, a subsidiary of the Group, has signed an exclusive license agreement with Ipsen, entitling it to receive a total payment of up to USD 1.06 billion.

Tag： SIMCERE PHARMA 02096.HK ClinicalTrialApproval

07:31

[ Yidu Tech (2158.HK): Secures Singapore DR BUDDY Implementation & Maintenance Project, Worth ~SGD 2.28 Million ] NewTimeSpace News: Yidu Tech Inc. (02158.HK) announced that its subsidiary, EVYD Research Private Limited, has recently won the bid for the implementation, support, and maintenance of the DR BUDDY project for Singapore Health Services Pte Ltd. The total project value is approximately SGD 2,277,996. This project serves as a key milestone for the company's expansion into the Singapore market.

Tag： YIDU TECH 02158.HK won the bid

10:13

[ EV DYNAMICS (00476.HK) plans to issue in total 3.84 million shares by subscription, with estimated net proceeds of HKD 1.98 million ] NewTimeSpace News：EV DYNAMICS (00476.HK) plans to issue in total 3.84 million shares by subscription, with estimated net proceeds of HKD 1.98 million.

Tag： EV DYNAMICS 00476.HK Issue shares

10:12

[ ACESO LIFE SCI (00474.HK) plans to issue in total 1.39 billion shares ] NewTimeSpace News：ACESO LIFE SCI (00474.HK) plans to issue in total 1.39 billion shares.

Tag： ACESO LIFE SCI 00474.HK rights shares

21:11

[ ILUVATAR COREX(09903.HK) closed 20.22% higher, the Hang Seng Semiconductors Sector posted broad gains ] NewTimeSpace news,By the close of trading on May 4, 2026, ILUVATAR COREX(09903.HK) saw a gain of 20.22% in its share price, closing at HKD 560. During the session, it reached an intraday high of HKD 570 and touched an intraday low of HKD 506.5.

Tag： ILUVATAR COREX 09903.HK NewTimeSpace

21:09

[ GEELY AUTO(00175.HK) will spend HKD 17.08 million to repurchase 742 thousand shares on May 4, 2026 ] NewTimeSpace news,GEELY AUTO(00175.HK) will spend HKD 17.08 million to repurchase 742 thousand shares on May 4, 2026.

Tag： GEELY AUTO 00175.HK NewTimeSpace

13:35

[ South Korea's KOSPI Index Rises to 6906.45! Xtrackers MSCI Korea UCITS ETF (02848.HK) Surges Over 5.4% Intraday ] On May 4, South Korea's KOSPI Index climbed to 6906.45 points, with gains reaching as high as 4.7%, setting a new intraday record.Xtrackers MSCI Korea UCITS ETF(02848.HK) surged over 5.4% during the session.

Tag： NewTimeSpace 02848.HK

22:00

[ YUHUA EDU(06169.HK): FY 25/26 Interim Report - Profit Attributable to Shareholders stood at CNY 270.25 million, YoY decrease of 33.4% ] NewTimeSpace News: April 30, 2026, YUHUA EDU(06169.HK) released its Interim Report for the period ended August 31, 2026, Total Revenue stood at CNY 1.26 billion, decreased by 1.16% YoY

Tag： YUHUA EDU 06169.HK financials

18:36

[ GOLDSTREAM INV (01328.HK) Signs Strategic Cooperation MOU with Manycore Tech, Plans to Launch AI Venture Capital Fund ] NewTimeSpace News: Goldstream Investment Limited (01328.HK) announced that it entered into a non-binding strategic cooperation memorandum of understanding (MOU) with Manycore Tech (00068.HK) on April 30, 2026. The two parties will explore cooperation in three major areas: overseas market expansion, the establishment of a joint venture venture capital fund focusing on spatial intelligence & full-scenario AI applications, and capital market collaboration.

Tag： GOLDSTREAM INV 01328.HK MANYCORE TECH strategic cooperation

18:28

[ CH BIOTECH SER (08037.HK) Announces Resignation of Executive Director He Xun ] New Timespace News: China Biotech Services Holdings Limited (08037.HK) announced that Mr. He Xun has tendered his resignation as executive director due to needing to devote more energy to other business affairs, effective May 1, 2026. Mr. He has confirmed that there is no disagreement with the board of directors.

Tag： CH BIOTECH SER 08037.HK resignation

17:47

[ CHINA EDU GROUP(00839.HK): FY 25/26 Interim Report - Profit Attributable to Shareholders stood at CNY 757 million, YoY decrease of 21.72% ] NewTimeSpace News: April 30, 2026, CHINA EDU GROUP(00839.HK) released its Interim Report for the period ended August 31, 2026, Total Revenue stood at CNY 3.79 billion, increased by 3.24% YoY

Tag： CHINA EDU GROUP 00839.HK financials

16:32

[ Premia China STAR50 ETF(03151.HK) rose 4.88% to close at HKD 10.960 ] Newtimespace News, as of April 30, Premia China STAR50 ETF(03151.HK) rose 4.88%, closing at HKD 10.960. During the session, its highest price was HKD 11.000, and the lowest price touched HKD 10.650.

Tag： ETF Premia China STAR50 ETF 03151.HK

16:22

[ Hang Seng China Enterprises Index ETF(02828.HK) fell 2.33% to close at HKD 88.880 ] Newtimespace News, as of April 30, Hang Seng China Enterprises Index ETF(02828.HK) fell 2.33%, closing at HKD 88.880. During the session, its highest price was HKD 90.000, and the lowest price touched HKD 88.720.

Tag： ETF Hang Seng China Enterprises Index ETF 02828.HK

15:50

[ CSOP Hang Seng HK-US TECH ETF(03442.HK) fell 0.36% to HKD 8.250 ] Newtimespace News, as of 15:45 on April 30, CSOP Hang Seng HK-US TECH ETF(03442.HK) fell 0.36% to HKD 8.250, with an asset size of approximately HKD 621 million.

Tag： ETF CSOP Hang Seng HK-US TECH ETF 03442.HK

15:45

[ Ping An of China CSI HK Dividend ETF(03070.HK) fell 1.28% to HKD 43.240 ] Newtimespace News, as of 15:40 on April 30, Ping An of China CSI HK Dividend ETF(03070.HK) fell 1.28% to HKD 43.240, with an asset size of approximately HKD 1.126 billion.

Tag： ETF Ping An of China CSI HK Dividend ETF 03070.HK

Scan QR Code

Download App